The advertising watchdog is investigating claims made by the makers of Nurofen after an Australian court ordered the company to stop selling several versions of the popular painkiller.
Australia's federal court ruled that Reckitt Benckiser, the British firm which produces the over-the-counter drug, deceived consumers by selling Nurofen painkillers that were identical to its standard ibuprofen pills, but nearly twice as expensive.
The UK's Advertising Standards Authority (ASA) has now confirmed it is investigating 12 complaints about a television advert for Nurofen Express.
The watchdog is examining whether the advert was misleading because it implies that the product directly targets muscles in the head.
It is also looking into whether viewers were misled by the claim that the Nurofen Express "gives you faster headache relief than standard paracetamol or ibuprofen".
An ASA spokesman said: "We received the complaints in February and launched an investigation in March. This is a complex case and our investigation is ongoing.
"The advertiser is providing evidence to substantiate its claims, we're carefully assessing that and we'll publish our findings in due course."
Australia's consumer watchdog launched court action in March, arguing that consumers were being tricked into thinking that four products - Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache - were designed to treat a specific type of pain, when in fact, they were all the same.
"None of the four products is any more or less effective than the others in treating any of the particular symptoms," Justice James Edelman wrote in his judgment.
A spokeswoman for Nurofen said the Australian court ruling did not affect its UK products and they would continue to be available.
Dr Aomesh Bhatt, the company's medical affairs director, said: "The Nurofen specific-pain range was launched with an intention to help consumers navigate their pain relief options, particularly within the grocery environment where there is no healthcare professional to assist decision making."
A Nurofen spokeswoman refused to comment on the ASA investigation as it was "ongoing".
The UK's Medicines and Healthcare Regulatory Products Agency (MHRA) has no remit on medicine pricing and tends to intervene only when a product's name or description makes a medically misleading claim.
A spokeswoman said: "MHRA is responsible for ensuring the quality, safety, and efficacy of medicines including over-the-counter painkillers.
"For over-the-counter medicines informative names are permitted to help patients select an appropriate product without input from a healthcare professional."
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here